Ignite Creation Date:
2024-05-05 @ 11:41 PM
Last Modification Date:
2024-10-26 @ 10:37 AM
Study NCT ID:
NCT01385371
Status:
COMPLETED
Last Update Posted:
2017-03-03
First Post:
2011-04-06
Brief Title:
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms With or Without Asthma P08067
Sponsor:
ALK-Abelló AS
Organization:
ALK-Abelló AS
Study Overview
Official Title:
A Multicenter Double-Blind Randomized Placebo-Controlled Parallel-Group Study Evaluating the Efficacy and Safety of Grass Phleum Pratense Sublingual Tablet SCH 697243 in Subjects Between 5 and 65 Years of Age With a History of Grass Pollen-Induced Rhinoconjunctivitis With or Without Asthma Protocol No P08067
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a study to evaluate the efficacy and safety of grass sublingual tablet SCH 697243 versus placebo in the treatment of grass pollen-induced allergic hayfever symptoms Participants will receive either the sublingual grass tablet or a placebo tablet during the study It is expected that those participants receiving the active sublingual grass tablet will have less hayfever symptoms and need less medications to treat hayfever symptoms during the grass pollen season
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MK-7243-001 | OTHER | Merck Protocol ID | None |